SV2016005282A - Nuevos compuestos
- Google Patents
Nuevos compuestos
Info
Publication number
SV2016005282A
SV2016005282ASV2016005282ASV2016005282ASV2016005282ASV 2016005282 ASV2016005282 ASV 2016005282ASV 2016005282 ASV2016005282 ASV 2016005282ASV 2016005282 ASV2016005282 ASV 2016005282ASV 2016005282 ASV2016005282 ASV 2016005282A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AGfiledCriticalBayer Pharma AG
Publication of SV2016005282ApublicationCriticalpatent/SV2016005282A/es
Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.